Point72 Middle East FZE’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,106	Closed	-$1.36M	–	1251
2023 Q3	$1.36M	Buy	+12,106	New	+$1.36M	0.04%	238
2023 Q1	–	Sell	-4,507	Closed	-$538K	–	1452
2022 Q4	$538K	Buy	+4,507	New	+$538K	0.02%	374